Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy

NCT02814864 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Pelvic Radiation Therapy
Radiation-induced Hemorrhagic Cystitis

Interventions

DRUG: Mesenchymal Stromal Cell (MSC) injections

Sponsor

Assistance Publique - Hôpitaux de Paris